BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2010
View Archived Issues
NicOx's NO-donating agents show preclinical promise in ophthalmology and pain
Read More
Serum bilirubin modulates response to bucindolol in patients with heart failure
Read More
Potent inhibitors identified of GIST-relevant kinases
Read More
Merck & Co. claims new cholesterol absorption inhibitors
Read More
Merck & Co. presents new sst5 receptor antagonists
Read More
NeuroSearch discovers new monoamine reuptake inhibitors
Read More
GlaxoSmithKline presents new AMPA receptor agonists
Read More
TransTech and Forest enter into agreement to develop GKAs
Read More
Vivalis and Sanofi Pasteur join to discover MAbs for infectious diseases
Read More
Nautilus Neurosciences launches Cambia for migraine in the U.S.
Read More
Simvastatin/ezetimibe combination promotes tumor growth in prostate cancer model
Read More
QBI-139 enters phase I trial in advanced/refractory solid tumors
Read More
Inhaled formoterol fumarate/glycopyrrolate is safe in healthy subjects
Read More
Protalix BioTherapeutics completes phase I trial of PRX-105
Read More
European Commission extends indication of RoActemra
Read More
Phase II data reported on IFN alpha-2b in patients with anogenital warts
Read More
Discovery receives FDA guidance for preclinical Surfaxin program in neonatal RDS
Read More
Idera reports preliminary phase I data on IMO-3100
Read More
Nektar Therapeutics reports phase II data on NKTR-102 in breast cancer
Read More
Aerovance presents phase IIb data on pitrakinra in eosinophilic asthma
Read More
NanoViricides' anti-HIV candidates efficacious against two HIV-1 isolates in vitro
Read More
Columbia Labs completes enrollment in phase III Prochieve trial
Read More
Eisai and Helsinn enter license agreement for antiemetic combination agent
Read More
Engrailed-2 proposed as diagnostic biomarker for prostate cancer
Read More
Phase III lubiprostone trial in idiopathic constipation complete
Read More
Eisai presents the year's product and financial highlights
Read More
